lifestyle.gamezon.net

Author: Celltrion Inc.

Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)

April 21, 2026
Celltrion announces U.S. availability of AVTOZMA® (tocilizumab-anoh) subcutaneous (SC) formulation

March 16, 2026
Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference

January 13, 2026
Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference

January 6, 2026